These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26802299)

  • 1. Prevalence of the Factor XIII Val34Leu Polymorphism in Korean Patients with Deep Vein Thrombosis.
    Kim SD; Hwang JK; Park SC; Kim JI; Won YS; Yun SS; Moon IS; Park JS
    Ann Vasc Surg; 2016 Apr; 32():57-64. PubMed ID: 26802299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor XIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep venous thrombosis.
    Van Hylckama Vlieg A; Komanasin N; Ariëns RA; Poort SR; Grant PJ; Bertina RM; Rosendaal FR
    Br J Haematol; 2002 Oct; 119(1):169-75. PubMed ID: 12358922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of factor XIII Val34Leu polymorphism in retinal artery occlusion.
    Weger M; Renner W; Stanger O; Schmut O; Deutschmann H; Wascher TC; Haas A
    Stroke; 2001 Dec; 32(12):2759-61. PubMed ID: 11739969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combined effect of fibrin formation and factor XIII A subunit Val34Leu polymorphism on the activation of factor XIII in whole plasma.
    Shemirani AH; Haramura G; Bagoly Z; Muszbek L
    Biochim Biophys Acta; 2006 Aug; 1764(8):1420-3. PubMed ID: 16920044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The factor XIII Val34Leu polymorphism: is it protective against idiopathic venous thromboembolism?
    Wells PS; Anderson JL; Rodger MA; Carson N; Grimwood RL; Doucette SP
    Blood Coagul Fibrinolysis; 2006 Oct; 17(7):533-8. PubMed ID: 16988547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of a common polymorphism in the factor XIII gene with venous thrombosis.
    Catto AJ; Kohler HP; Coore J; Mansfield MW; Stickland MH; Grant PJ
    Blood; 1999 Feb; 93(3):906-8. PubMed ID: 9920839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor XIII Val34Leu polymorphism does not contribute to the prevention of thrombotic complications in patients with antiphospholipid syndrome.
    Diz-Kucukkaya R; Hancer VS; Inanc M; Nalcaci M; Pekcelen Y
    Lupus; 2004; 13(1):32-5. PubMed ID: 14870915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The factor XIII-A Val34Leu polymorphism decreases whole blood clot mass at high fibrinogen concentrations.
    Kattula S; Bagoly Z; Tóth NK; Muszbek L; Wolberg AS
    J Thromb Haemost; 2020 Apr; 18(4):885-894. PubMed ID: 31989767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between factor XIII Val34Leu polymorphism and early myocardial infarction.
    Hancer VS; Diz-Kucukkaya R; Bilge AK; Ozben B; Oncul A; Ergen G; Nalcaci M
    Circ J; 2006 Mar; 70(3):239-42. PubMed ID: 16501286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction.
    Elbaz A; Poirier O; Canaple S; Chédru F; Cambien F; Amarenco P
    Blood; 2000 Jan; 95(2):586-91. PubMed ID: 10627467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor XIII Val34Leu is a genetic factor involved in the etiology of venous thrombosis.
    Franco RF; Reitsma PH; Lourenço D; Maffei FH; Morelli V; Tavella MH; Araújo AG; Piccinato CE; Zago MA
    Thromb Haemost; 1999 May; 81(5):676-9. PubMed ID: 10365735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels.
    de la Red G; Tàssies D; Espinosa G; Monteagudo J; Bové A; Plaza J; Cervera R; Reverter JC
    Thromb Haemost; 2009 Feb; 101(2):312-6. PubMed ID: 19190815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor XIII Val34Leu polymorphism in primary intracerebral haemorrhage.
    Corral J; Iniesta JA; González-Conejero R; Villalón M; Rivera J; Vicente V
    Hematol J; 2000; 1(4):269-73. PubMed ID: 11920201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor XIII Val34Leu variant is protective against venous thromboembolism: a HuGE review and meta-analysis.
    Wells PS; Anderson JL; Scarvelis DK; Doucette SP; Gagnon F
    Am J Epidemiol; 2006 Jul; 164(2):101-9. PubMed ID: 16740590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure.
    Ariëns RA; Philippou H; Nagaswami C; Weisel JW; Lane DA; Grant PJ
    Blood; 2000 Aug; 96(3):988-95. PubMed ID: 10910914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familial thrombophilia.
    Balogh I; Szôke G; Kárpáti L; Wartiovaara U; Katona E; Komáromi I; Haramura G; Pfliegler G; Mikkola H; Muszbek L
    Blood; 2000 Oct; 96(7):2479-86. PubMed ID: 11001900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor XIII val34leu and the risk of myocardial infarction.
    Franco RF; Pazin-Filho A; Tavella MH; Simões MV; Marin-Neto JA; Zago MA
    Haematologica; 2000 Jan; 85(1):67-71. PubMed ID: 10629595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A common mutation in the gene for coagulation factor XIII-A (VAL34Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases.
    Gemmati D; Serino ML; Ongaro A; Tognazzo S; Moratelli S; Resca R; Moretti M; Scapoli GL
    Am J Hematol; 2001 Jul; 67(3):183-8. PubMed ID: 11391716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Coagulation Factors VIII/XI/XIII Polymorphisms With Coagulation Factor Activities and Deep Vein Thrombosis After Artificial Joints Replacement.
    Su W; Lv M; Xu X; Li B; Liu HY; Ning B; Li Y
    Am J Ther; 2016; 23(6):e1547-e1553. PubMed ID: 26934731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor XIII Val34Leu polymorphism and gamma-chain cross-linking at the site of microvascular injury in healthy and coumadin-treated subjects.
    Undas A; Brzezinska-Kolarz B; Brummel-Ziedins K; Musial J; Szczeklik A; Mann KG
    J Thromb Haemost; 2005 Sep; 3(9):2015-21. PubMed ID: 16102108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.